Skip to main content
OpenTrials

Clinical trial condition

Hemic and Lymphatic Diseases

Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

21,127 public trials 3,991 recruiting studies
Refine in advanced search Browse all conditions

Hemic and Lymphatic Diseases trial results

Recruiting

Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma

NCT05145400

Conditions
Blood Protein Disorders, Cancer, Cardiovascular Diseases, +13 more
Locations
  • University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
  • Levine Cancer Institute Charlotte, North Carolina, United States
  • Duke Comprehensive Cancer Center Durham, North Carolina, United States
  • Novant Health New Hanover Regional Medical Center Wilmington, North Carolina, United States
View Trial Details
Recruiting

DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8)

NCT06539182

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Disease Attributes, +14 more
Locations
  • Research Site Hefei, Anhui, China
  • Research Site Beijing, Beijing Municipality, China
  • Research Site Beijing, Beijing Municipality, China
  • Research Site Guangzhou, Guandong, China
View all 17 locations
View Trial Details
Recruiting

A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome

NCT06847867

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations
  • GSK Investigational Site Goodyear, Arizona, United States
  • GSK Investigational Site Duarte, California, United States
  • GSK Investigational Site Irvine, California, United States
  • GSK Investigational Site New Haven, Connecticut, United States
View all 39 locations
View Trial Details
Recruiting

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

NCT04139304

Conditions
Ann Arbor Stage I Diffuse Large B-Cell Lymphoma, Ann Arbor Stage II Diffuse Large B-Cell Lymphoma, Ann Arbor Stage III Diffuse Large B-Cell Lymphoma, +13 more
Locations
  • University of Miami Miller School of Medicine Miami, Florida, United States
  • University of Illinois at Chicago Chicago, Illinois, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details

Related conditions